VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
35 hedge funds and large institutions have $25.4M invested in Viracta Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
35
Holding in Top 10
–
Calls
$119K
Puts
–
Top Buyers
| 1 | +$529K | |
| 2 | +$189K | |
| 3 | +$104K | |
| 4 |
TI
Telemetry Investments
New York
|
+$71.3K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$51.5K |
Top Sellers
| 1 | -$1.1M | |
| 2 | -$1.03M | |
| 3 | -$158K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$36.9K |
| 5 |
Renaissance Technologies
New York
|
-$31.3K |